Martin G Schwacha Selected Research

Estrogens (Estrogen)

10/2008	Mechanism of estrogen-mediated improvement in cardiac function after trauma-hemorrhage: p38-dependent normalization of cardiac Akt phosphorylation and glycogen levels.
08/2008	Estrogen ameliorates trauma-hemorrhage-induced lung injury via endothelial nitric oxide synthase-dependent activation of protein kinase G.
06/2008	Mechanism of estrogen-mediated intestinal protection following trauma-hemorrhage: p38 MAPK-dependent upregulation of HO-1.
10/2007	Mechanism of estrogen-mediated attenuation of hepatic injury following trauma-hemorrhage: Akt-dependent HO-1 up-regulation.
09/2007	Mechanism of the nongenomic effects of estrogen on intestinal myeloperoxidase activity following trauma-hemorrhage: up-regulation of the PI-3K/Akt pathway.
06/2007	Role of p38 mitogen-activated protein kinase pathway in estrogen-mediated cardioprotection following trauma-hemorrhage.
06/2007	The PI3K/Akt pathway mediates the nongenomic cardioprotective effects of estrogen following trauma-hemorrhage.
05/2007	Downregulation of migration inhibitory factor is critical for estrogen-mediated attenuation of lung tissue damage following trauma-hemorrhage.
05/2007	Downregulation of TLR4-dependent ATP production is critical for estrogen-mediated immunoprotection in Kupffer cells following trauma-hemorrhage.
04/2007	G protein-coupled receptor 30-dependent protein kinase A pathway is critical in nongenomic effects of estrogen in attenuating liver injury after trauma-hemorrhage.
01/2007	Tissue compartment-specific role of estrogen receptor subtypes in immune cell cytokine production following trauma-hemorrhage.
01/2006	Flutamide restores cardiac function after trauma-hemorrhage via an estrogen-dependent pathway through upregulation of PGC-1.
05/2002	Estrogen pretreatment protects males against hypoxia-induced immune depression.

Articles by Research Topic

Disease

43	Wounds and Injuries (Trauma) 10/2008 - 01/2002
40	Hemorrhage 10/2008 - 01/2002
3	Poisoning 05/2008 - 08/2006
3	Burns 05/2008 - 07/2006
3	Sepsis (Septicemia) 08/2006 - 01/2002
2	Anoxia (Hypoxia) 09/2006 - 05/2002
2	Hemorrhagic Shock 12/2004 - 12/2003

Drug/Important Bio-Agent (IBA)

13	Estrogens (Estrogen)FDA Link 10/2008 - 05/2002
6	Estradiol (Estrace)FDA LinkGeneric 06/2008 - 04/2003
4	p38 Mitogen-Activated Protein KinasesIBA 06/2008 - 09/2006
3	Flutamide (Eulexin)FDA LinkGeneric 08/2008 - 01/2006
3	Estrogen Receptor betaIBA 09/2006 - 02/2006
2	Protein Kinases (Protein Kinase)IBA 03/2008 - 06/2007
2	Peroxidase (Myeloperoxidase)IBA 09/2007 - 02/2006
2	Endothelin-1 (Endothelin 1)IBA 01/2007 - 09/2004
2	Interleukin-6 (Interleukin 6)IBA 09/2006 - 12/2004
2	AndrostenediolIBA 08/2006 - 02/2005
2	Estrogen ReceptorsIBA 05/2006 - 03/2003
2	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 07/2005 - 12/2003
2	Interleukin-10 (Interleukin 10)IBA 06/2004 - 05/2004
2	Prolactin Receptors (Prolactin Receptor)IBA 12/2003 - 05/2002
2	Gonadal Steroid Hormones (Sex Hormones)IBA 04/2002 - 01/2002
1	GlycogenIBA 10/2008
1	Chemokine CCL3IBA 08/2008
1	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 08/2008
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 08/2008
1	neutrophil cytosol factor 67KIBA 05/2008
1	Heme Oxygenase-1IBA 05/2008
1	Protein Tyrosine PhosphatasesIBA 05/2008
1	Estrogen Receptor alphaIBA 01/2008
1	Mitogen-Activated Protein KinasesIBA 07/2007
1	Adenosine Triphosphate (ATP)IBA 05/2007
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 04/2007
1	GTP-Binding Proteins (G-Protein)IBA 04/2007
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2007
1	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2007
1	Lidocaine (Xylocaine)FDA LinkGeneric 11/2006
1	src-Family KinasesIBA 09/2006
1	Interleukin-18 (Interleukin 18)IBA 08/2006
1	CorticosteroneIBA 08/2006
1	Analgesics (Analgesic Drugs)IBA 07/2006
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2006
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 02/2005

Therapy/Procedure

1	Resuscitation 10/2008